Can a tailored therapy help young people overcome the stigma of psychosis?

NCT ID NCT04889911

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This trial tests a modified therapy called NECT-YA, designed for young people aged 15-24 who have recently experienced a first episode of psychosis. The therapy aims to reduce self-stigma and improve how they see themselves, which may help them stay engaged in treatment. Participants receive NECT-YA alongside standard Coordinated Specialty Care, and the study compares this combination to standard care alone. The goal is to see if the adapted therapy is feasible, acceptable, and shows promise in improving treatment engagement and well-being.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Narrative Enhancement and Cognitive Therapy adapted for young adults (NECT-YA), combined with Coordinated Specialty Care (CSC)
What this could lead to
If successful, this could provide a tailored therapy to help young people recovering from psychosis feel less stigmatized and stay engaged in their care.
What could go wrong
This is a small, early-stage study focused on feasibility and preliminary effects, so results may not be definitive or widely applicable. The therapy is new and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIRST EPISODE PSYCHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Eskenazi Health, PARC Program

    Indianapolis, Indiana, 46202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.